These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 33556300)
1. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate. Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300 [TBL] [Abstract][Full Text] [Related]
2. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice. Zhu C; Xu Y; Liu ZH; Wan XC; Li DX; Tai LL Biomed Pharmacother; 2018 Jan; 97():168-173. PubMed ID: 29091862 [TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate reduces uric acid levels by regulating xanthine oxidase activity and uric acid excretion in vitro and in vivo. Li F; Liu Y; Xie Y; Liu Z; Zou G Ann Palliat Med; 2020 Mar; 9(2):331-338. PubMed ID: 32008337 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of epigallocatechin gallate (EGCG) in ameliorating hyperuricemia: insights into gut microbiota and intestinal function in a mouse model. Yu H; Lou Z; Wu T; Wan X; Huang H; Wu Y; Li B; Tu Y; He P; Liu J Food Funct; 2024 Jun; 15(11):6068-6081. PubMed ID: 38757391 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight. Scalia S; Marchetti N; Bianchi A Molecules; 2013 Jan; 18(1):574-87. PubMed ID: 23292326 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Hatano T; Tsugawa M; Kusuda M; Taniguchi S; Yoshida T; Shiota S; Tsuchiya T Phytochemistry; 2008 Dec; 69(18):3111-6. PubMed ID: 17889045 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis. Chiu YH; Wu YW; Hung JI; Chen MC Acta Biomater; 2021 Aug; 130():223-233. PubMed ID: 34087444 [TBL] [Abstract][Full Text] [Related]
8. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953 [TBL] [Abstract][Full Text] [Related]
9. Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate. Fangueiro JF; Parra A; Silva AM; Egea MA; Souto EB; Garcia ML; Calpena AC Int J Pharm; 2014 Nov; 475(1-2):181-90. PubMed ID: 25175728 [TBL] [Abstract][Full Text] [Related]
10. Production of hydrogen peroxide and methionine sulfoxide by epigallocatechin gallate and antioxidants. Sakagami H; Arakawa H; Maeda M; Satoh K; Kadofuku T; Fukuchi K; Gomi K Anticancer Res; 2001; 21(4A):2633-41. PubMed ID: 11724332 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways. Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma antioxidant activity in rats given excess EGCg with reference to endogenous antioxidants concentrations and assay methods. Yokotani K; Umegaki K Free Radic Res; 2017 Feb; 51(2):193-199. PubMed ID: 28166649 [TBL] [Abstract][Full Text] [Related]
14. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. Proniuk S; Liederer BM; Blanchard J J Pharm Sci; 2002 Jan; 91(1):111-6. PubMed ID: 11782902 [TBL] [Abstract][Full Text] [Related]
15. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea. Bannerman B; Xu L; Jones M; Tsu C; Yu J; Hales P; Monbaliu J; Fleming P; Dick L; Manfredi M; Claiborne C; Bolen J; Kupperman E; Berger A Cancer Chemother Pharmacol; 2011 Nov; 68(5):1145-54. PubMed ID: 21400028 [TBL] [Abstract][Full Text] [Related]
17. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease. Torres RJ; Puig JG Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316 [TBL] [Abstract][Full Text] [Related]
18. Degradation kinetics of chlorogenic acid at various pH values and effects of ascorbic acid and epigallocatechin gallate on its stability under alkaline conditions. Narita Y; Inouye K J Agric Food Chem; 2013 Jan; 61(4):966-72. PubMed ID: 23298331 [TBL] [Abstract][Full Text] [Related]
19. Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice. Qin Z; Wang S; Lin Y; Zhao Y; Yang S; Song J; Xie T; Tian J; Wu S; Du G Acta Pharm Sin B; 2018 Mar; 8(2):306-315. PubMed ID: 29719791 [TBL] [Abstract][Full Text] [Related]
20. Albumin stabilizes (-)-epigallocatechin gallate in human serum: binding capacity and antioxidant property. Bae MJ; Ishii T; Minoda K; Kawada Y; Ichikawa T; Mori T; Kamihira M; Nakayama T Mol Nutr Food Res; 2009 Jun; 53(6):709-15. PubMed ID: 19437485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]